Northern Trust’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Buy |
402,396
+13,475
| +3% | +$686K | ﹤0.01% | 1632 |
|
|
2025
Q1 | $17.5M | Sell |
388,921
-10,623
| -3% | -$479K | ﹤0.01% | 1704 |
|
|
2024
Q4 | $16.5M | Buy |
399,544
+32,059
| +9% | +$1.33M | ﹤0.01% | 1819 |
|
|
2024
Q3 | $14.3M | Buy |
367,485
+90,119
| +32% | +$3.51M | ﹤0.01% | 1842 |
|
|
2024
Q2 | $9.48M | Sell |
277,366
-3,713
| -1% | -$127K | ﹤0.01% | 2030 |
|
|
2024
Q1 | $7.06M | Sell |
281,079
-6,956
| -2% | -$175K | ﹤0.01% | 2272 |
|
|
2023
Q4 | $8.5M | Buy |
288,035
+12,801
| +5% | +$378K | ﹤0.01% | 2172 |
|
|
2023
Q3 | $8.7M | Buy |
275,234
+1,375
| +0.5% | +$43.5K | ﹤0.01% | 2103 |
|
|
2023
Q2 | $7.08M | Buy |
273,859
+59,662
| +28% | +$1.54M | ﹤0.01% | 2293 |
|
|
2023
Q1 | $5.15M | Buy |
214,197
+1,512
| +0.7% | +$36.3K | ﹤0.01% | 2455 |
|
|
2022
Q4 | $4.15M | Buy |
212,685
+4,523
| +2% | +$88.2K | ﹤0.01% | 2599 |
|
|
2022
Q3 | $4.37M | Buy |
208,162
+31,396
| +18% | +$660K | ﹤0.01% | 2573 |
|
|
2022
Q2 | $3.44M | Buy |
176,766
+90,439
| +105% | +$1.76M | ﹤0.01% | 2749 |
|
|
2022
Q1 | $1.9M | Sell |
86,327
-2,908
| -3% | -$64K | ﹤0.01% | 3130 |
|
|
2021
Q4 | $1.42M | Buy |
89,235
+490
| +0.6% | +$7.81K | ﹤0.01% | 3399 |
|
|
2021
Q3 | $1.77M | Sell |
88,745
-7,233
| -8% | -$144K | ﹤0.01% | 3350 |
|
|
2021
Q2 | $1.66M | Sell |
95,978
-957
| -1% | -$16.6K | ﹤0.01% | 3405 |
|
|
2021
Q1 | $1.92M | Sell |
96,935
-1,399
| -1% | -$27.7K | ﹤0.01% | 3266 |
|
|
2020
Q4 | $1.72M | Sell |
98,334
-2,655
| -3% | -$46.3K | ﹤0.01% | 3268 |
|
|
2020
Q3 | $1.95M | Buy |
100,989
+635
| +0.6% | +$12.2K | ﹤0.01% | 3077 |
|
|
2020
Q2 | $1.95M | Buy |
100,354
+30,448
| +44% | +$593K | ﹤0.01% | 3055 |
|
|
2020
Q1 | $978K | Buy |
69,906
+23,294
| +50% | +$326K | ﹤0.01% | 3231 |
|
|
2019
Q4 | $1.14M | Buy |
46,612
+9,799
| +27% | +$240K | ﹤0.01% | 3354 |
|
|
2019
Q3 | $370K | Buy |
+36,813
| New | +$370K | ﹤0.01% | 3616 |
|